SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is surging after reporting a massive spike in order backlog to over $60 billion, alongside a significant margin expansion that doubled prior guidance. Community discussion is dominated by expectations of a short squeeze, with investors debating the company's long-term growth potential versus concerns over historical accounting and governance challenges.

Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovance is experiencing significant upward momentum and high trading volume, fueled by institutional accumulation and growing anticipation ahead of the upcoming Q2 earnings report. The community is actively discussing the company's potential for a short squeeze, its derisked pipeline, and long-term expansion opportunities in oncology that support an optimistic outlook for the stock.

GE Vernova, Inc. engages in the electric power industry. It operates through the following segments: Power, Wind, and Electrification. The Power segment offers design, manufacture, and servicing gas, nuclear, hydro, and steam technologies, providing a critical foundation of dispatchable, flexible, stable, and reliable power. The Wind segment manages wind generation technologies, including onshore and offshore wind turbines and blades. The Electrification segment refers to the grid solutions, power conversion, electrification software, and solar and storage solutions technologies required for the transmission, distribution, conversion, storage, and orchestration of electricity from point of generation to point of consumption. The company was founded November 9, 2021 and is headquartered in Cambridge, MA.

GE Vernova Inc.

GE Vernova is capturing intense market attention as investors monitor its crucial role in the AI infrastructure buildout, specifically regarding power generation and grid modernization. While the stock has seen volatility following recent analyst commentary and mixed options positioning, community sentiment remains focused on the company's massive order backlog and its position as a long-term beneficiary of surging electricity demand from data centers.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JasmyCoin is capturing significant attention as investors debate its long-term potential in data ownership amid volatile price swings and conflicting community sentiment. While some see the recent chart consolidation as a setup for a breakout, others remain skeptical, pointing to the emergence of related ecosystem tokens and a general lack of recent project updates as reasons for caution.

Corning, Inc. engages in the provision of glass for notebook computers, flat panel desktop monitors, display televisions, and other information display applications, carrier network and enterprise network products for the telecommunications industry, ceramic substrates for gasoline and diesel engines in automotive and heavy-duty vehicle markets, laboratory products for the scientific community and polymer products for biotechnology applications, optical materials for the semiconductor industry and the scientific community, and polycrystalline silicon products and other technologies. It operates through the following segments: Optical Communications, Display, Specialty Materials, Automotive, and Life Sciences. The Optical Communications segment is classified into two main product groupings: carrier and enterprise network. The carrier network group consists of products and solutions for optical-based communications infrastructure for services such as video, data, and voice communications. The enterprise network group consists primarily of optical-based communication networks sold to businesses, governments, and individuals for their own use. The Display Technologies segment manufactures glass substrates for flat panel displays, including organic light-emitting diodes and liquid crystal displays that are used primarily in televisions, notebook computers, desktop monitors, tablets, and handheld devices. The Specialty Materials segment is involved in the manufacture of products that provide material formulations for glass, glass ceramics and crystals, and precision metrology instruments and software. The Automotive segment manufactures ceramic substrates and filter products for emissions control in mobile applications around the world as well as technical glass and optic products and solutions for the interior and exterior of vehicles. The Life Sciences segment develops, manufactures, and supplies laboratory products. The company was founded by Amory Houghton Sr. in 1851 and is headquartered in Corning, NY.

Corning, Inc.

Corning is trending as investors aggressively rotate into AI infrastructure, with the community actively debating whether the stock's recent volatility is a short-term momentum unwind or a long-term opportunity driven by its critical role in fiber optic and data center connectivity. Traders are focused on key support levels and price targets, weighing bullish sentiment regarding Corning's optical patents against concerns about overvaluation and broader semiconductor sector exhaustion.

Coherent Corp. engages in the development, refinement, manufacturing, and marketing of engineered materials, opto-electronic components and devices, and lasers for use in the industrial, communications, electronics, and instrumentation markets. It operates through the following segments: Networking, Materials, and Lasers. The Networking segment leverages compound semiconductor technology platforms and deep knowledge of end-user applications. The Materials segment markets engineered materials and optoelectronic devices. The Lasers segment serves industrial customers in semiconductor capital equipment, display capital equipment, precision manufacturing, and aerospace and defense, as well as instrumentation customers in life sciences and scientific research. The company was founded by Carl J. Johnson in 1971 and is headquartered in Saxonburg, PA.

Coherent Corp

Coherent Corp is trending as investors aggressively buy the dip, fueled by the company's critical role in the photonics and optical interconnect supply chain as AI data centers reach the physical limitations of copper. The community is heavily focused on Coherent's vertical integration and strategic partnerships with industry giants, viewing recent price volatility as a rotation opportunity within the broader, ongoing secular AI infrastructure buildout.

XPeng, Inc. engages in the design, development, manufacture, and marketing of smart electric vehicles. Its products are environmentally friendly vehicles, namely an SUV (the G3) and a four-door sports sedan (the P7). It also provides a range of services to the clients, including supercharging service, maintenance service, ride-hailing service and vehicle leasing service. The company was founded by Xiao Peng He, Heng Xia, and Tao He in 2015 and is headquartered in Guangzhou, China.

XPeng Inc - ADR

XPeng is trending as investors weigh its pivot toward a comprehensive 'physical AI' platform, including humanoid robotics and autonomous driving, against broader concerns regarding consistent delivery growth and sector-wide margin pressure. While community sentiment remains split between long-term optimism over proprietary tech like the Turing chip and frustration over persistent stock price volatility, market attention is currently focused on the company's ability to translate AI R&D into a sustainable, high-margin revenue model amidst an increasingly competitive global EV landscape.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is experiencing heightened investor scrutiny and volatility, driven by a 30% short float and speculative discussions regarding potential buyout scenarios, despite internal management criticism and ongoing regulatory uncertainty surrounding its Duchenne pipeline. The community is actively debating whether recent trading volume indicates institutional accumulation or manipulation, while some remain focused on long-term value catalysts like the siRNA pipeline and upcoming earnings performance.

Chevron Corp. engages in the provision of oil and gas energy solutions. It provides crude oil and natural gas, manufactures transportation fuels, lubricants, petrochemicals, and additives, and develops technologies that enhance business and the industry. It operates through the Upstream and Downstream segments. The Upstream segment consists of the exploration, development, and production of crude oil and natural gas, the liquefaction, transportation, and regasification associated with liquefied natural gas, the transporting of crude oil by major international oil export pipelines, the processing, transporting, storage, and marketing of natural gas, and a gas-to-liquids plant. The Downstream segment consists of the refining of crude oil into petroleum products, the marketing of crude oil and refined products, the transporting of crude oil and refined products by pipeline, marine vessel, motor equipment, and rail car, and the manufacturing and marketing of commodity petrochemicals and plastics for industrial uses and fuel & lubricant additives. The company was founded on September 10, 1879 and is headquartered in Houston, TX.

Chevron Corp.

Chevron is seeing significant investor focus as the energy sector continues to outperform, driven by ongoing geopolitical tensions impacting crude supply and the company's strategic move to power AI data centers via a landmark natural gas deal with Microsoft. While the community remains divided over the impact of potential geopolitical peace agreements on the stock's momentum, bulls are highlighting Chevron's strong free cash flow, consistent dividend history, and the massive scale of its infrastructure investments as key indicators of long-term value.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

The United States Oil Fund is trending due to mounting geopolitical volatility in the Middle East, specifically rising tensions around the Strait of Hormuz and reports of Iranian infrastructure strikes impacting global energy transit. Investors and community members are closely monitoring the potential for supply chain disruptions, leading to intense debate over the sustainability of current energy price levels and the broader inflationary risks.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

CRVO Stock Rockets Nearly 100% On Patent Win Before Offering News Cools Rally

Equity

The new patent for neflamapimod covers the treatment of dementia with Lewy bodies in patients without significant signs of Alzheimer’s disease.


Emerging Growth Stocks Enter Breakout Territory

A wave of high-impact developments is drawing investor attention as multiple emerging growth companies advance toward potentially transformative milestones. $CRVO, $NTHI, $CAST, $LNKS, $BFLY, $QS, $APWC

Brains, AI Imaging, and Breakthrough Antibiotics Ignite Investor Buzz

The healthcare and biotechnology sector continues to generate a steady stream of meaningful catalysts as companies advance novel therapies, secure regulatory milestones, strengthen intellectual property portfolios, and expand commercialization efforts. Recent developments from CervoMed (NASDAQ:CRVO), Butterfly Network (NYSE:BFLY), NeOnc (NASDAQ:NTHI), Spero Therapeutics (NASDAQ:SPRO), GSK (NYSE:GSK), and IceCure Medical (NASDAQ:ICCM) highlight several emerging themes shaping the sector, including neurodegenerative disease treatment, AI-powered diagnostics, antimicrobial resistance, minimally invasive cancer care, and synthetic biology.

Power Hour Breakouts: Clinical Catalysts and New Highs Send Traders Hunting for the Next Winner

Clinical milestones, regulatory progress, insider buying, and newly public biotechnology platforms are among the leading themes for today’s power hour. $CRVO, $NTHI, $SLBT, $SPCX, $WULF, $AMAT, $EW, $OSCR

Biotech Bulls Stampede as Clinical Wins and Milestones Fuel Momentum

Multiple clinical-stage companies are delivered meaningful regulatory, clinical, and corporate milestones. From brain cancer drug development and cell therapy expansion to neurodegenerative disease programs and cardiovascular breakthroughs, investors were presented with a wave of catalysts that are driving enthusiasm across several emerging healthcare names. Traders appeared particularly focused on companies advancing toward late-stage clinical development, securing new regulatory clearances, or gaining broader visibility through public market events. $NTHI, $SLBT, $CRVO, $EWTX

Why Did CRVO Stock Crash 22% In Pre-Market Trading Today?

CervoMed announced a $10.5 million private placement financing, with participation from institutional healthcare investors and company insiders.

Pelthos Therapeutics Inc. (PTHS) Reports Q1 Loss, Beats Revenue Estimates

Pelthos Therapeutics Inc. (PTHS) delivered earnings and revenue surprises of +22.75% and +12.03%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Caribou Biosciences, Inc. (CRBU) Reports Q1 Loss, Misses Revenue Estimates

Caribou Biosciences (CRBU) delivered earnings and revenue surprises of +21.81% and -4.12%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

IDEAYA Biosciences, Inc. (IDYA) Reports Q1 Loss, Misses Revenue Estimates

IDEAYA Biosciences (IDYA) delivered earnings and revenue surprises of -3.35% and -35.62%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

CervoMed Inc. (CRVO) Reports Q4 Loss, Lags Revenue Estimates

CERVOMED INC (CRVO) delivered earnings and revenue surprises of -10.93% and -98.06%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

CervoMed, Inc. is a clinical stage biotechnology company. It engages in the business of advancing CNS focused therapeutics to benefit patients with a range of degenerative diseases of the brain. The company is currently developing neflamapimod, an investigational orally administered small molecule brain penetrant that inhibits p38MAP kinase alpha. CervoMed, Inc. was founded in1995 and is headquartered in Boston, MA.

CervoMed Inc

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$2.89
Prev Close	$2.79
Open	$2.77
Dividend Yield	0.00%
50-Day Moving Average	$3.27
Beta	1.38
Avg. Volume	15.99M
PE Ratio	-0.88

52-Week High	$13.13
52-Week Low	$2.13
Market Capitalization	$37.74M
EPS (Annual)	-$2.98
Price to Book	2.52
Revenue Per Employee	$267,100.67

Feed

News

Sentiment

Earnings

Fundamentals

Info

CRVOCervoMed Inc

Latest CRVO News